Empiric quinidine therapy for asymptomatic Brugada syndrome: Time for a prospective registry
- 3 December 2008
- journal article
- creative concept
- Published by Elsevier in Heart Rhythm
- Vol. 6 (3), 401-404
- https://doi.org/10.1016/j.hrthm.2008.11.030
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada SyndromeCirculation: Arrhythmia and Electrophysiology, 2008
- Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humansJCI Insight, 2008
- Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene ( GPD1-L ) Decreases Cardiac Na + Current and Causes Inherited ArrhythmiasCirculation, 2007
- Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 GeneCirculation, 2007
- Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac DeathCirculation, 2007
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Can potentially significant polymorphic ventricular arrhythmias initiated by programmed stimulation be distinguished from those that are nonspecific?American Heart Journal, 1986
- Programmed ventricular stimulation in patients without spontaneous ventricular tachycardiaAmerican Heart Journal, 1984
- Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias.Circulation, 1984
- Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required.Circulation, 1984